New CAR-T Cancer Studies Aim to Treat Those With No Other Options – Futurism
Futurism |
New CAR-T Cancer Studies Aim to Treat Those With No Other Options
Futurism Two studies have been published detailing the results of clinical trials involving CAR-T treatment, where a patient’s own T-cells are used to fight cancer. CAR T Progress: Global Submissions for Kymriah, 42% Ongoing Response With Yescarta in ZUMA-1 PatientsAJMC.com Managed Markets Network India: US FDA Approves Yescarta™ (Axicabtagene Ciloleucel): Becomes First CAR T Therapy Approved For The …Mondaq News Alerts ASH: Long-term CAR-T data look good for Gilead—but good …FiercePharma StreetInsider.com –Pharmacy Today, American Pharmacists Association, pharmacist.com all 13 news articles » |
|
Patients’ individual genomes may affect efficacy, safety of gene editing
Science Daily The study analyzed 7,444 previously published whole-genome sequences. Based on a list of about 30 disease-related DNA targets that researchers are interested in altering through gene editing, the researchers made a second list of nearly 3,000 guide … |
Popular Science |
New trials show cancer immunotherapy can be incredibly effective—and incredibly dangerous
Popular Science In the past decade, immunotherapies have become an increasingly promising way of combatting cancer. Most of them work by hijacking the body’s immune system and employing it to fight disease. But one treatment has arguably shown the most promise … Fighting the disease: Novel immunotherapy brings new hope for cancer patientsHindustan Times New immunotherapy to help fight cancer developedGreater Kashmir Global CAR T therapy trial shows high rates of durable remission for non-Hodgkin’s lymphomaScience Daily KERA News all 22 news articles » |